Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN
It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021
Bharat Biotech International confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.
It has signed an agreement for the delivery of COVAXIN during Q2 and Q3 2021.
The company informed through a statement, “The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus. There is a strong interest in COVAXIN from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently.”